The cost of debt collection in the secondary market is indeed quite high compared to dollars recovered. The reason companies sell debt is because they don’t wish to be burdened by efforts/costs that take away from the primary productive function of their organization. They, therefore, sell this debt, after reasonable collection efforts, at a deep discount in the secondary market. The debt, which can be hundreds or thousands of accounts, can be over a year old and is charged off as bad debt by the seller. Sometimes the acquiring company then resells the debt after failing in their collection efforts. Yes, debt collection is a tough business. The goal, often times, is to simply not lose money on the purchased debt. Honestly, an OTC start up company that can avoid losses, maintain share structure (no excessive dilution), stay current with regulatory compliance and satisfy shareholder demands for transparency is a huge winner. Be fair with your personal assessments in the OTC. How many of the 10,000 plus OTC traded companies show profits? I suggest it’s a small percentage. Yet, there is much money made by focusing not on how profitable a ticker is, but rather on how it manages to maintain the prospect of making big profits while at the same time avoiding losses. That my friends, is what drives the trading action in the OTC market and gives BLLB the opportunity to become a 10 or 20 bagger from present levels. Don’t let the occasional negativity posted here be a cause to abandon your prospect of profiting. We can all make money here, even if BLLB does nothing more than NOT lose money.
News 
Market Data 
Discover 
AI
